Ozan Taylan Dursun

Ozan Taylan Dursun, MD, PhD(c), MPH(c) has a diverse work experience spanning various roles and organizations. Currently, they serve as an Associate Director and Clinical Trial Physician at Idorsia Pharmaceuticals Ltd since September 2021. Prior to this, they worked as a Clinical Researcher at Charité from November 2018 onwards. Ozan Taylan has also held the position of Senior Clinical Research Physician at Parexel from January 2021 to September 2021. From October 2019 to January 2021, they served as a Clinical Research Physician at Accelerated Enrollment Solutions. Earlier in their career, they gained experience as a Resident Doctor in Psychiatry and Neurology at Neuro-Psychiatrisches Zentrum Riem from June 2016 to September 2017, and as an Intern in the same field at the same institution from July 2015 to September 2015. Additionally, they worked as an Emergency Room Physician at Dumlupinar University in 2015. Impressively, they also held leadership roles at the Turkish Medical Students' International Committee (TurkMSIC) from 2011 to 2014, where they served as the National Exchange Director, Project Manager, and Trainer. Overall, Ozan Taylan Dursun has a solid background in clinical research, clinical trial management, and medical administration.

Ozan Taylan Dursun, MD, PhD(c), MPH(c), obtained their Doctor of Medicine (MD) degree from Dokuz Eylul University in 2014. In 2011, they completed an Internship Program in Medicine at Universitat Autònoma de Barcelona, and in 2010, they completed another Internship Program at Alexandria University. Dursun is currently pursuing a Doctoral Degree in Medicine at Humboldt-Universität zu Berlin, which began in 2018 and is expected to be completed in 2021. Additionally, they are pursuing a Master of Public Health (MPH) degree from the London School of Hygiene and Tropical Medicine, University of London, with an anticipated completion date in 2023.